MYGN
Myriad Genetics Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report3 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Myriad Genetics Inc
5.97
−0.07 · −1.18%
post 6.63 +11.08%
No thesis.
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $62.2M | 12.23% | +22.51% | |
| 2 | Millennium ManagementMillennium | $37.8M | 7.44% | −0.73% | |
| 3 | Vestal Point CapitalVestal Point Capital | $32.7M | 6.44% | +248.00% | |
| 4 | State StreetState Streetindex-like | $28.5M | 5.60% | +12.68% | |
| 5 | D. E. ShawD. E. Shaw | $26.2M | 5.15% | +1.83% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $23.3M | 4.58% | +4.00% | |
| 7 | Acadian Asset ManagementAcadian | $17.9M | 3.51% | +35.45% | |
| 8 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $17.6M | 3.46% | +19.26% | |
| 9 | AQR Capital ManagementAQR | $15.8M | 3.11% | +44.68% | |
| 10 | Morgan StanleyMorgan Stanley | $14.2M | 2.79% | −21.70% | |
| 11 | Geode Capital ManagementGeodeindex-like | $13.8M | 2.71% | +4.17% | |
| 12 | Goldman Sachs GroupGoldman Sachs | $11.7M | 2.31% | −13.07% | |
| 13 | Jacobs Levy Equity ManagementJacobs Levy Equity | $10.8M | 2.12% | −9.43% | |
| 14 | Charles Schwab Investment ManagementCharles Schwabindex-like | $9.9M | 1.96% | −3.37% | |
| 15 | Qube Research & TechnologiesQube Research & Technologies | $9.5M | 1.87% | −1.46% | |
| 16 | Citadel AdvisorsCitadel | $9.1M | 1.78% | +223.11% | |
| 17 | Federated InvestorsFederated Investors | $9.0M | 1.76% | −20.54% | |
| 18 | Two Sigma InvestmentsTwo Sigma | $8.9M | 1.75% | +21.31% | |
| 19 | NuveenNuveenindex-like | $8.8M | 1.74% | +68.18% | |
| 20 | Mackenzie FinancialMackenzie Financial | $8.8M | 1.72% | new | |
| 21 | Connor, Clark & Lunn Investment ManagementConnor, Clark & Lunn | $8.0M | 1.58% | +6.76% | |
| 22 | Standard Life AberdeenStandard Life Aberdeen | $7.5M | 1.47% | +17.88% | |
| 23 | Marshall WaceMarshall Wace | $7.0M | 1.37% | +10.79% | |
| 24 | Dimensional Fund AdvisorsDimensional | $6.0M | 1.18% | +42.34% | |
| 25 | Assenagon Asset ManagementAssenagon | $5.9M | 1.16% | −28.72% |
194 managers report $508.3M of Myriad Genetics on form 13F for the quarter ended Jun 30 '26. 25 of them hold 80% of it; BlackRock is largest at 12.23%.
Linked news
No implied move.
No implied move.
Expected move
No implied move.